Cargando…

Clinicopathological correlates of pyramidal signs in multiple system atrophy

OBJECTIVE: Pyramidal signs are common but often under‐recognized in multiple system atrophy (MSA). The clinicopathological correlates of pyramidal signs in MSA are not well characterized. The present study aims to understand the role of pyramidal signs in MSA. METHODS: We examined 40 autopsy‐confirm...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chi‐Ying R., Viswanathan, Anisha, Chen, Tiffany X., Mitsumoto, Hiroshi, Vonsattel, Jean P., Faust, Phyllis L., Kuo, Sheng‐Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268870/
https://www.ncbi.nlm.nih.gov/pubmed/35593123
http://dx.doi.org/10.1002/acn3.51576
_version_ 1784744092429713408
author Lin, Chi‐Ying R.
Viswanathan, Anisha
Chen, Tiffany X.
Mitsumoto, Hiroshi
Vonsattel, Jean P.
Faust, Phyllis L.
Kuo, Sheng‐Han
author_facet Lin, Chi‐Ying R.
Viswanathan, Anisha
Chen, Tiffany X.
Mitsumoto, Hiroshi
Vonsattel, Jean P.
Faust, Phyllis L.
Kuo, Sheng‐Han
author_sort Lin, Chi‐Ying R.
collection PubMed
description OBJECTIVE: Pyramidal signs are common but often under‐recognized in multiple system atrophy (MSA). The clinicopathological correlates of pyramidal signs in MSA are not well characterized. The present study aims to understand the role of pyramidal signs in MSA. METHODS: We examined 40 autopsy‐confirmed MSA cases in New York Brain Bank. The pyramidal signs were quantified by an established rating scale, summarized as the pyramidal score. We assessed whether pyramidal scores are associated with autonomic, parkinsonism, and cerebellar features and survival. We also examined whether the density of glial cytoplasmic inclusions (GCIs) in the motor cortex and its underlying white matter is associated with the pyramidal score. RESULTS: MSA parkinsonian type cases have higher pyramidal scores compared to cerebellar type cases (p = 0.017). MSA cases with high pyramidal scores are more likely to have laryngeal stridor (OR = 4.89, p = 0.022), but less likely to have orthostatic hypotension (OR = 0.11, p = 0.006) and erectile dysfunction (OR = 0.05, p = 0.018). MSA cases with high pyramidal scores do not differ from those with low pyramidal scores in terms of bowel dysfunction, dry eyes and mouth, and survival. Finally, MSA cases with more GCIs in the motor cortex have higher pyramidal scores compared to those with few GCIs (p = 0.017). INTERPRETATION: Pyramidal signs in MSA are associated with the parkinsonian subtype, laryngeal stridor, and certain autonomic dysfunction.
format Online
Article
Text
id pubmed-9268870
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92688702022-07-14 Clinicopathological correlates of pyramidal signs in multiple system atrophy Lin, Chi‐Ying R. Viswanathan, Anisha Chen, Tiffany X. Mitsumoto, Hiroshi Vonsattel, Jean P. Faust, Phyllis L. Kuo, Sheng‐Han Ann Clin Transl Neurol Research Articles OBJECTIVE: Pyramidal signs are common but often under‐recognized in multiple system atrophy (MSA). The clinicopathological correlates of pyramidal signs in MSA are not well characterized. The present study aims to understand the role of pyramidal signs in MSA. METHODS: We examined 40 autopsy‐confirmed MSA cases in New York Brain Bank. The pyramidal signs were quantified by an established rating scale, summarized as the pyramidal score. We assessed whether pyramidal scores are associated with autonomic, parkinsonism, and cerebellar features and survival. We also examined whether the density of glial cytoplasmic inclusions (GCIs) in the motor cortex and its underlying white matter is associated with the pyramidal score. RESULTS: MSA parkinsonian type cases have higher pyramidal scores compared to cerebellar type cases (p = 0.017). MSA cases with high pyramidal scores are more likely to have laryngeal stridor (OR = 4.89, p = 0.022), but less likely to have orthostatic hypotension (OR = 0.11, p = 0.006) and erectile dysfunction (OR = 0.05, p = 0.018). MSA cases with high pyramidal scores do not differ from those with low pyramidal scores in terms of bowel dysfunction, dry eyes and mouth, and survival. Finally, MSA cases with more GCIs in the motor cortex have higher pyramidal scores compared to those with few GCIs (p = 0.017). INTERPRETATION: Pyramidal signs in MSA are associated with the parkinsonian subtype, laryngeal stridor, and certain autonomic dysfunction. John Wiley and Sons Inc. 2022-05-20 /pmc/articles/PMC9268870/ /pubmed/35593123 http://dx.doi.org/10.1002/acn3.51576 Text en © 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Lin, Chi‐Ying R.
Viswanathan, Anisha
Chen, Tiffany X.
Mitsumoto, Hiroshi
Vonsattel, Jean P.
Faust, Phyllis L.
Kuo, Sheng‐Han
Clinicopathological correlates of pyramidal signs in multiple system atrophy
title Clinicopathological correlates of pyramidal signs in multiple system atrophy
title_full Clinicopathological correlates of pyramidal signs in multiple system atrophy
title_fullStr Clinicopathological correlates of pyramidal signs in multiple system atrophy
title_full_unstemmed Clinicopathological correlates of pyramidal signs in multiple system atrophy
title_short Clinicopathological correlates of pyramidal signs in multiple system atrophy
title_sort clinicopathological correlates of pyramidal signs in multiple system atrophy
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268870/
https://www.ncbi.nlm.nih.gov/pubmed/35593123
http://dx.doi.org/10.1002/acn3.51576
work_keys_str_mv AT linchiyingr clinicopathologicalcorrelatesofpyramidalsignsinmultiplesystematrophy
AT viswanathananisha clinicopathologicalcorrelatesofpyramidalsignsinmultiplesystematrophy
AT chentiffanyx clinicopathologicalcorrelatesofpyramidalsignsinmultiplesystematrophy
AT mitsumotohiroshi clinicopathologicalcorrelatesofpyramidalsignsinmultiplesystematrophy
AT vonsatteljeanp clinicopathologicalcorrelatesofpyramidalsignsinmultiplesystematrophy
AT faustphyllisl clinicopathologicalcorrelatesofpyramidalsignsinmultiplesystematrophy
AT kuoshenghan clinicopathologicalcorrelatesofpyramidalsignsinmultiplesystematrophy